TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
Hofseth BioCare ASA
Closing information (x1000 NOK)
| Closing information | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
| Turnover |
190,815
|
119,128
|
76,878 |
| Financial expenses |
13,293
|
13,136
|
11,578 |
| Earnings before taxes |
-106,684
|
-137,390
|
-126,464 |
| Total assets |
390,119
|
411,030
|
415,973 |
| Current assets |
131,002
|
175,749
|
170,311 |
| Current liabilities |
251,877
|
172,228
|
150,933 |
| Equity capital |
41,140
|
148,030
|
140,378 |
| - share capital |
3,951
|
3,951
|
3,578 |
Financial ratios
| Fiscal year | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
| Solvency |
10.5%
|
36.0%
|
33.7% |
| Turnover per employee | |||
| Profit as a percentage of turnover |
-55.9%
|
-115.3%
|
-164.5% |
| Return on assets (ROA) |
-23.9%
|
-30.2%
|
-27.6% |
| Current ratio |
52.0%
|
102.0%
|
112.8% |
| Return on equity (ROE) |
-259.3%
|
-92.8%
|
-90.1% |
| Change turnover |
71,687
|
42,250
|
24,364 |
| Change turnover % |
60%
|
55%
|
46% |
| Chg. No. of employees | |||
| Chg. No. of employees % |
Total value of public sale
| Fiscal year | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.